New study on hepatitis C drug treatment in vivo and in vitro

Hepatitis C virus (HCV) infection affects 4 million in the US and is the prirmary cause of liver cirrhosis and liver cancer. New research shows that daclatasvir, an ant - HCV drug, has two modes of action and provides a more accurate estimate of the HCV half-life.

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/h...